Preclinical data underline a possible importance of Trop-2 as a target in head and neck cancer: Trop-2 overexpression correlated with lymph node metastasis and dismal prognosis in laryngeal cancer [24]. Here, TACSTD2 is linked to laryngeal carcinoma.